Amputation

0
Pipeline Programs
4
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Design Therapeutics
2 programs
Peer Visitation ProgramN/A1 trial
eADAPT trainingN/A1 trial
Active Trials
NCT03326115UnknownEst. Aug 2021
NCT04238533UnknownEst. Jul 2021
Ottobock
OttobockNEW YORK, NY
1 program
1C70N/A1 trial
Active Trials
NCT05628064CompletedEst. Jun 2023
Providence Therapeutics
1 program
Active Knee ProsthesisN/A1 trial
Active Trials
NCT00771589UnknownEst. Apr 2009
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Our Emergency Fasciotomy and Amputation ExperiencesN/A1 trial
Active Trials
NCT06764446CompletedEst. Mar 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
City TherapeuticsOur Emergency Fasciotomy and Amputation Experiences
Ottobock1C70
Design TherapeuticsPeer Visitation Program
Design TherapeuticseADAPT training
Providence TherapeuticsActive Knee Prosthesis

Clinical Trials (5)

NCT06764446City TherapeuticsOur Emergency Fasciotomy and Amputation Experiences

Our Emergency Fasciotomy and Amputation Experiences

Start: Jan 2025Est. completion: Mar 2025
N/ACompleted

1C70 Feasibility Study

Start: Nov 2022Est. completion: Jun 2023
N/ACompleted
NCT03326115Design TherapeuticsPeer Visitation Program

Effectiveness of a Peer Visitation Program to Improve Patient Activation and Quality of Life During Amputation Rehabilitation

Start: Dec 2020Est. completion: Aug 2021
N/AUnknown

Enhanced Auto-Diagnostic Adaptive Precision Trainer for Myoelectric Prosthetic Users

Start: Mar 2020Est. completion: Jul 2021
N/AUnknown

Active Knee Prosthesis Study for Improvement of Locomotion for Above Knee Amputees

Start: May 2008Est. completion: Apr 2009
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

4 companies competing in this space